3630 results for «566»
3630 results
Featured research - Tricuspid valve intervention: the TRIPLACE registry
17 Nov 2025 – From PCR London Valves 2025
This session features cutting-edge research on tricuspid valve interventions, including insights from the TRIPLACE registry on orthotopic TTVR thrombosis, predictive value of three-dimensional tricuspid annulus measurements for procedural outcomes, early clinical experiences with novel TTVR systems, and procedural clipping strategies based on results from the BRIGHT...
Featured research - TAVI: Predictive tools, AI innovation and reintervention strategies
17 Nov 2025 – From PCR London Valves 2025
This session presents cutting-edge research in TAVI, covering the development of predictive models for clinical valve thrombosis, comparative analyses between self-expandable and balloon-expandable valves from the Greek TAVI registry, and the emerging role of AI-guided Heart Team decisions. It also examines outcomes of reintervention strategies following...
Mitral TEER and LAA closure - LIVE Case
17 Nov 2025 – From PCR London Valves 2025
Watch a LIVE case followed by a recorded case regarding a 91-year-old female with permanent AF, LAD PCI three months earlier, and recurrent GID bleeding who presented with symptomatic severe primary mitral regurgitation due to P2 prolapse and flail. CT imaging showed a LAA with a...
Paravalvular leak closure - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session is dedicated to paravalvular leak (PVL) closure techniques, featuring percutaneous approaches after surgical valve implantation and TAVI complications such as annulus rupture. It includes advanced management using multiple plugs for long-tunnel mitral PVLs, innovative transformation from pop-up to plug strategies, and transapical approaches following...
Valve interventions in grown-up congenital heart disease
17 Nov 2025 – From PCR London Valves 2025
This session presents complex valve interventions in patients with grown-up congenital heart disease, showcasing innovative transcatheter approaches including combined TAVI and pulmonary valve implantation in high-risk patients. Cases highlight management strategies in elderly patients with concomitant conditions such as patent ductus arteriosus and severe left ventricular...
TAVI complications
17 Nov 2025 – From PCR London Valves 2025
This session delves into the management of complications arising during TAVI procedures, presenting real-world cases such as major vascular events including abdominal aortic dissection and catastrophic iliac artery perforation. It also covers technical solutions for valve embolisation and valve deformation due to calcific aorta, providing valuable...
TAVI for pure aortic regurgitation: different animal, different challenges, different approaches
17 Nov 2025 – From PCR London Valves 2025
This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.
TAVI in aortic regurgitation - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter aortic valve implantation in the setting of aortic regurgitation, a challenging clinical entity. It features novel techniques such as pump-assisted deployment and the use of deflectable self-expanding systems, as well as management of patients with prior valve-sparing aortic root surgery and...
From diagnosis to device: decision-making and planning for mitral valve interventions
17 Nov 2025 – From PCR London Valves 2025
This session offers a comprehensive overview of decision-making and procedural planning for transcatheter mitral valve interventions. It emphasizes patient-specific factors, advanced imaging for valve morphology assessment, device selection, and the integration of emerging technologies to tailor optimal treatment strategies for mitral valve disease.
Transcatheter mitral valve-in-valve: transcatheter rescue, balloon migration & more
17 Nov 2025 – From PCR London Valves 2025
This session addresses transcatheter mitral valve-in-valve and valve-in-ring interventions in complex clinical contexts. It includes cases of rescue procedures in valvular dysfunction, ECMO-assisted mitral valve-in-ring implantation in severe left ventricular dysfunction, and innovative approaches to mitral ring anatomy challenges, offering practical insights and procedural tips for...
Early Career Research Award Final
17 Nov 2025 – From PCR London Valves 2025
Highlighting pioneering research in structural heart interventions, this session presents studies on the impact of transcatheter tricuspid valve replacement (TTVR) on left ventricular geometry and function, myocardial remodeling in aortic stenosis, physiological responses after mitral and tricuspid edge-to-edge repairs, advancing the understanding of device effects on...
Complex combined interventions - Part 3
17 Nov 2025 – From PCR London Valves 2025
This session highlights complex combined transcatheter interventions, demonstrating simultaneous management of multiple valvular and aortic pathologies. Cases include percutaneous treatment of degenerated bioprosthetic valves, TAVI in rheumatic small annuli with multivalvular disease, and endovascular repair of ascending aortic pseudoaneurysm, illustrating comprehensive strategies for multifaceted cardiovascular disease.
Cutting-edge research in transcatheter tricuspid valve therapies
16 Nov 2025 – From PCR London Valves 2025
This session highlights cutting-edge research on tricuspid valve interventions, including the impact of inflow gradients on outcomes, global registry data on bicaval valve therapy, patient selection algorithms, and prognostic score validations for severe tricuspid regurgitation.
Procedural imaging for tricuspid valve interventions
16 Nov 2025 – From PCR London Valves 2025
Master procedural imaging techniques essential for tricuspid valve interventions, including TOE views, multi-phase reconstruction, and 3D/4D steering. This session also covers quantification of residual tricuspid regurgitation post-device deployment and the appropriate use of intracardiac echocardiography.
Complex valve-in-valve leaflet modification - LIVE Case
17 Nov 2025 – From PCR London Valves 2025
Watch this LIVE case followed by a recorded case, regarding a 79-year-old male with permanent AF and a history of surgical aortic valve replacement in 2010 (Magna Ease 25) who presented with symptomatic bioprosthetic valve stenosis, normal LV function, and no CAD. A Sapien 3 Ultra...
Tricuspid interventions: knowns and unknowns
17 Nov 2025 – From PCR London Valves 2025
Explore the evolving landscape of transcatheter tricuspid valve interventions in this session, which presents the latest evidence from registries and randomized trials. Discussions include the new Euro tricuspid regurgitation risk score, clinical controversies, real-world patient scenarios, and insights into optimal medical therapy and device selection to...
TAVI valve-in-valve - Challenging clinical scenarios
17 Nov 2025 – From PCR London Valves 2025
This session focuses on the complexities of valve-in-valve TAVI procedures, highlighting challenging clinical scenarios such as managing severely regurgitant rapid deployment valves and degenerated stentless bioprostheses. It provides detailed insights into overcoming procedural barriers and strategies for complex valve-in-valve transcatheter aortic valve replacement (TAVR) interventions.
TAVI in patients with concomitant valve and coronary artery disease
17 Nov 2025 – From PCR London Valves 2025
Focused on patients with concomitant valve and coronary artery disease, this session examines evaluation strategies for aortic stenosis burden, integrates recent trial data on combined TAVI and PCI, and discusses optimal management approaches in complex multi-valve disease scenarios through detailed case presentations and clinical outcomes.
TAVI: alternative access
17 Nov 2025 – From PCR London Valves 2025
This session addresses alternative access routes for TAVI in patients with challenging vascular anatomies. It includes innovative approaches such as transapical TAV-in-TAV procedures, transcaval implantation in emergency settings, and techniques for patients with hostile iliofemoral access, showcasing adaptive strategies when conventional access is not feasible.
Unravel the complexity of multi-valve disease
17 Nov 2025 – From PCR London Valves 2025
This session unpacks the complexities inherent in multi-valve disease involving combined mitral and tricuspid regurgitation. It emphasizes diagnostic challenges, the critical role of invasive hemodynamics in decision-making, and strategies for optimal timing and staging of interventions, demonstrated through illustrative patient cases.
